New High-Throughput Method Detects Growth Hormone Releasing Peptides in Urine
Background
Growth Hormone Releasing Peptides (GHRPs), including hexarelin, ipamorelin, and GHRP-6, are synthetic compounds designed to stimulate growth hormone release. These peptides, which are synthetic met-enkephalin analogues containing unnatural D-amino acids, are often misused as performance-enhancing drugs (PEDs) in both human sports and horse racing. The lack of a robust, high-throughput analytical method has made regulating their use challenging, highlighting the critical need for an effective detection system in biological samples like urine.
Results
The developed method successfully detected all eight GHRPs or their metabolites in urine samples from rats following intravenous administration, confirming its broad applicability. The novel derivatization technique proved highly effective, significantly improving the chromatographic separation and detection of these challenging basic peptides. The comprehensive validation confirmed the method's reliability across all tested parameters, indicating its suitability for routine anti-doping analysis. This robust analytical performance ensures accurate and sensitive detection of GHRPs. The developed high-throughput LC-MS/MS method successfully detected all eight GHRPs and their metabolites in rat urine, demonstrating its potential for robust anti-doping analysis with high specificity and sensitivity.
Why It Matters
This advanced analytical method provides a crucial tool for anti-doping agencies to combat the illicit use of GHRPs in both equine and human sports. By enabling reliable and high-throughput detection, it helps ensure fair competition and protects athlete health. The implementation of this robust screening method could significantly enhance the effectiveness of anti-doping programs worldwide. Future steps involve further validation in human and equine samples from controlled administration studies, paving the way for its adoption in accredited anti-doping laboratories.